{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:10:01Z","timestamp":1756663801455,"version":"3.44.0"},"reference-count":35,"publisher":"BMJ","issue":"Suppl 1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"UNITAID","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2025,6,25]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Identifying SARS-CoV-2 infection in high-risk populations is critical. We examined SARS-CoV-2 case detection (CD) in \u2018TA\u2019 versus \u2018screen-and-test\u2019 models of rapid antigen testing integration in maternal neonatal and child health (MNCH), HIV and tuberculosis (TB) clinics in Cameroon (C) and Kenya (K).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>From May to October 2022, we conducted a cluster-randomised trial with 10 facilities per country randomised to the \u2018test-all\u2019 (TA) intervention arm or the standard \u2018screen-and-test\u2019 (ST) arm. Individuals aged &gt;2 years attending HIV, TB and MNCH clinics were eligible for SARS-CoV-2 testing. The primary outcome was the SARS-CoV-2 CD, defined as the number of SARS-CoV-2 infections detected per 1 000 attendees in MNCH, HIV and TB clinics. We estimated the intervention arm-specific CDs by combining the facility-specific estimates using a weighted approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 80 828 attendee visits in the TA model (63 492 C, 17 336 K) and 71 254 in the ST model (56 589 C, 14 665 K). About 17.4% (K) and 29.0% (C) were tested under the TA model. The overall CD was 2.90 (95% CI:1.76 to 4.79) per 1 000 attendee visits in the TA model and 1.20 (95% CI:0.73 to 1.99) in the ST model (RR=2.41, 95%\u2009CI:1.18 to 4.91, p=0.018). The TA model had a significantly higher SARS-CoV-2 CD in MNCH clinics (2.91 vs 1.11, p=0.012), while CD estimates in HIV (2.88 vs 1.40, p=0.203) and TB (10.24 vs 4.57, p=0.051) clinics, although higher in TA model compared with ST model, were not statistically different.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The TA model identified more SARS-CoV-2 cases than the screen-and-test model, even with low testing coverage. The TA model could be considered in future epidemics for early detection of SARS-CoV-2 infection among vulnerable populations, but effective implementation requires additional human resources to manage testing in high volume clinics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05382130\">NCT05382130<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjph-2023-000873","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T03:40:14Z","timestamp":1752464414000},"page":"e000873","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating SARS-CoV-2 rapid antigen testing in maternal, neonatal and child health, HIV and tuberculosis services in Cameroon and Kenya: a cluster randomised trial of two testing models"],"prefix":"10.1136","volume":"2","clinical-trial-number":[{"clinical-trial-number":"nct05382130","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-7786","authenticated-orcid":false,"given":"Nilesh","family":"Bhatt","sequence":"first","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-7938","authenticated-orcid":false,"given":"Rose Otieno","family":"Masaba","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8747-9610","authenticated-orcid":false,"given":"Boris","family":"Tchounga","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Yaound\u00e9, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Yemaneberhan","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Simo","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9634-8532","authenticated-orcid":false,"given":"Tatiana Djikeussi","family":"Katcho","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Yaound\u00e9, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ndimbii","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Siamba","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Mwancha-Kwasa","sequence":"additional","affiliation":[{"name":"Kiambu County Health Research and Development Unit, Kiambu, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilienne","family":"Epee","sequence":"additional","affiliation":[{"name":"Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Cecile","family":"Zoung-Kanyi Bissek","sequence":"additional","affiliation":[{"name":"Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0925-4113","authenticated-orcid":false,"given":"Sharee","family":"Pearson","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Appolinaire","family":"Tiam","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Guay","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"},{"name":"George Washington University Milken Institute School of Public Health, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoderick","family":"Machekano","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"key":"2025083110375884000_2.Suppl_1.e000873.1","unstructured":"World Health Organization . Kenya country overview. 2023. Available: https:\/\/www.who.int\/countries\/ken [Accessed 10 Feb 2023]."},{"key":"2025083110375884000_2.Suppl_1.e000873.2","unstructured":"World Health Organization . Coronavirus (COVID-19) dashboard. 2022. Available: https:\/\/covid19.who.int [Accessed 12 Jan 2022]."},{"key":"2025083110375884000_2.Suppl_1.e000873.3","unstructured":"World Health Organization . Cameroon country overview. 2023. Available: https:\/\/www.who.int\/countries\/cmr [Accessed 10 Feb 2023]."},{"key":"2025083110375884000_2.Suppl_1.e000873.4","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1002\/jmv.27119","article-title":"An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality","volume":"93","author":"Wang","year":"2021","journal-title":"J Med Virol"},{"key":"2025083110375884000_2.Suppl_1.e000873.5","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26740"},{"key":"2025083110375884000_2.Suppl_1.e000873.6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jmv.26311","article-title":"Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis","volume":"93","author":"Gao","year":"2021","journal-title":"J Med Virol"},{"key":"2025083110375884000_2.Suppl_1.e000873.7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6944e3"},{"key":"2025083110375884000_2.Suppl_1.e000873.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.011"},{"key":"2025083110375884000_2.Suppl_1.e000873.9","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.ajogmf.2020.100107","article-title":"Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis","volume":"2","author":"Di Mascio","year":"2020","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"key":"2025083110375884000_2.Suppl_1.e000873.10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/25787489.2021.1975608","article-title":"HIV and COVID-19: review of clinical course and outcomes","volume":"22","author":"Barbera","year":"2021","journal-title":"HIV Res Clin Pract"},{"key":"2025083110375884000_2.Suppl_1.e000873.11","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","article-title":"Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19","volume":"9","author":"Bertagnolio","year":"2022","journal-title":"Lancet HIV"},{"key":"2025083110375884000_2.Suppl_1.e000873.12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamapediatrics.2021.2770","article-title":"Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection","volume":"175","author":"Paul","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2025083110375884000_2.Suppl_1.e000873.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30917-X"},{"key":"2025083110375884000_2.Suppl_1.e000873.14","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1016\/S2214-109X(21)00053-X","article-title":"Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey","volume":"9","author":"Mulenga","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025083110375884000_2.Suppl_1.e000873.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565"},{"key":"2025083110375884000_2.Suppl_1.e000873.16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41586-020-2488-1","article-title":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019","volume":"584","author":"Lavezzo","year":"2020","journal-title":"Nature New Biol"},{"key":"2025083110375884000_2.Suppl_1.e000873.17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","article-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020","volume":"25","author":"Mizumoto","year":"2020","journal-title":"Euro Surveill"},{"key":"2025083110375884000_2.Suppl_1.e000873.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009316 [published Online First: 2020\/04\/14]"},{"key":"2025083110375884000_2.Suppl_1.e000873.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1375","article-title":"Covid-19: four fifths of cases are asymptomatic, China figures indicate","volume":"369","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"2025083110375884000_2.Suppl_1.e000873.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258700","article-title":"Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures","volume":"16","author":"Sanchez-Taltavull","year":"2021","journal-title":"PLoS One"},{"key":"2025083110375884000_2.Suppl_1.e000873.21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd5393","article-title":"Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening","volume":"7","author":"Larremore","year":"2021","journal-title":"Sci Adv"},{"key":"2025083110375884000_2.Suppl_1.e000873.22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16818","article-title":"Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States","volume":"3","author":"Paltiel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025083110375884000_2.Suppl_1.e000873.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839.e4"},{"key":"2025083110375884000_2.Suppl_1.e000873.24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12874-022-01699-2","article-title":"Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method","volume":"22","author":"Thompson","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"2025083110375884000_2.Suppl_1.e000873.25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12879-022-07075-1","article-title":"Preventing COVID-19 outbreaks through surveillance testing in healthcare facilities: a modelling study","volume":"22","author":"Litwin","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025083110375884000_2.Suppl_1.e000873.26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10729-020-09526-0","article-title":"Repeat SARS-CoV-2 testing models for residential college populations","volume":"24","author":"Chang","year":"2021","journal-title":"Health Care Manag Sci"},{"key":"2025083110375884000_2.Suppl_1.e000873.27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajic.2022.11.002","article-title":"SARS-CoV-2 antigen rapid tests and universal screening for COVID-19 Omicron variant among hospitalized children","volume":"51","author":"Kam","year":"2023","journal-title":"Am J Infect Control"},{"key":"2025083110375884000_2.Suppl_1.e000873.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.01.002"},{"key":"2025083110375884000_2.Suppl_1.e000873.29","doi-asserted-by":"crossref","unstructured":"Park K , Sung H , Kim MN . Prospective Evaluation of SARS-CoV-2 Rapid Antigen Test for Screening of Asymptomatic Caregivers. Clin Lab 2023;69. doi:10.7754\/Clin.Lab.2022.220644","DOI":"10.7754\/Clin.Lab.2022.220644"},{"key":"2025083110375884000_2.Suppl_1.e000873.30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijid.2021.11.011","article-title":"Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings","volume":"114","author":"Wee","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2025083110375884000_2.Suppl_1.e000873.31","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare10050790","article-title":"SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects","volume":"10","author":"Borro","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"2025083110375884000_2.Suppl_1.e000873.32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","article-title":"Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes","volume":"19","author":"Togun","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025083110375884000_2.Suppl_1.e000873.33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s12879-021-06498-6","article-title":"Integration of community-based testing data into national HIV surveillance in Poland, Serbia and Slovakia within the framework of INTEGRATE project","volume":"21","author":"Fern\u00e0ndez-L\u00f3pez","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025083110375884000_2.Suppl_1.e000873.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-019-0714-9","article-title":"Integration of HIV testing services into family planning services: a systematic review","volume":"16","author":"Narasimhan","year":"2019","journal-title":"Reprod Health"},{"key":"2025083110375884000_2.Suppl_1.e000873.35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2017.00071","article-title":"Integration of HIV Testing into Maternal, Newborn, and Child Health Weeks for Improved Case Finding and Linkage to Prevention of Mother-to-Child Transmission Services in Benue State, Nigeria","volume":"5","author":"Akinleye","year":"2017","journal-title":"Front Public Health"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2023-000873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:38:12Z","timestamp":1756661892000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2023-000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"journal-issue":{"issue":"Suppl 1","published-online":{"date-parts":[[2025,7,13]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjph-2023-000873"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2023-000873","relation":{},"ISSN":["2753-4294"],"issn-type":[{"type":"electronic","value":"2753-4294"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}